US Patent Issued to RIKEN, Hiroshima Institute of Life Sciences on Dec. 16 for "Human NTCP-binding antibody capable of inhibiting infection of hepatitis B virus (HBV) to human hepatocytes" (Japanese Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,461, issued on Dec. 16, was assigned to RIKEN (Wako, Japan) and Hiroshima Institute of Life Sciences (Hiroshima, Japan).

"Human NTCP-binding antibody capable of inhibiting infection of hepatitis B virus (HBV) to human hepatocytes" was invented by Toshitada Takemori (Saitama, Japan), Akiko Sugimoto (Saitama, Japan), Michishige Harada (Saitama, Japan), Mikako Shirouzu (Saitama, Japan), Takehisa Matsumoto (Saitama, Japan), Tomomi Someya (Saitama, Japan), Hiroyuki Osada (Saitama, Japan), Yushi Futamura (Saitama, Japan), Kunitada Shimotohno (Tokyo), Hironori Nishitsuji (Tokyo), Kazuaki Chayama (Hiroshima, Japan) and Daiki Miki (Hiroshima, Japan).

According to the abstract* released by...